BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

265 related articles for article (PubMed ID: 16981694)

  • 1. Despite having a common P1 Leu, eglin C inhibits alpha-lytic proteinase a million-fold more strongly than does turkey ovomucoid third domain.
    Qasim MA; Van Etten RL; Yeh T; Saunders C; Ganz PJ; Qasim S; Wang L; Laskowski M
    Biochemistry; 2006 Sep; 45(38):11342-8. PubMed ID: 16981694
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Thermodynamic criterion for the conformation of P1 residues of substrates and of inhibitors in complexes with serine proteinases.
    Qasim MA; Lu SM; Ding J; Bateman KS; James MN; Anderson S; Song J; Markley JL; Ganz PJ; Saunders CW; Laskowski M
    Biochemistry; 1999 Jun; 38(22):7142-50. PubMed ID: 10353824
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Structural insights into the non-additivity effects in the sequence-to-reactivity algorithm for serine peptidases and their inhibitors.
    Lee TW; Qasim MA; Laskowski M; James MN
    J Mol Biol; 2007 Mar; 367(2):527-46. PubMed ID: 17266986
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Contribution of peptide bonds to inhibitor-protease binding: crystal structures of the turkey ovomucoid third domain backbone variants OMTKY3-Pro18I and OMTKY3-psi[COO]-Leu18I in complex with Streptomyces griseus proteinase B (SGPB) and the structure of the free inhibitor, OMTKY-3-psi[CH2NH2+]-Asp19I.
    Bateman KS; Huang K; Anderson S; Lu W; Qasim MA; Laskowski M; James MN
    J Mol Biol; 2001 Jan; 305(4):839-49. PubMed ID: 11162096
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Interscaffolding additivity. Association of P1 variants of eglin c and of turkey ovomucoid third domain with serine proteinases.
    Qasim MA; Ganz PJ; Saunders CW; Bateman KS; James MN; Laskowski M
    Biochemistry; 1997 Feb; 36(7):1598-607. PubMed ID: 9048543
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Binding of amino acid side-chains to S1 cavities of serine proteinases.
    Lu W; Apostol I; Qasim MA; Warne N; Wynn R; Zhang WL; Anderson S; Chiang YW; Ogin E; Rothberg I; Ryan K; Laskowski M
    J Mol Biol; 1997 Feb; 266(2):441-61. PubMed ID: 9047374
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Affinity and specificity of serine endopeptidase-protein inhibitor interactions. Empirical free energy calculations based on X-ray crystallographic structures.
    Krystek S; Stouch T; Novotny J
    J Mol Biol; 1993 Dec; 234(3):661-79. PubMed ID: 8254666
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Water molecules participate in proteinase-inhibitor interactions: crystal structures of Leu18, Ala18, and Gly18 variants of turkey ovomucoid inhibitor third domain complexed with Streptomyces griseus proteinase B.
    Huang K; Lu W; Anderson S; Laskowski M; James MN
    Protein Sci; 1995 Oct; 4(10):1985-97. PubMed ID: 8535235
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Two conformational states of Turkey ovomucoid third domain at low pH: three-dimensional structures, internal dynamics, and interconversion kinetics and thermodynamics.
    Song J; Laskowski M; Qasim MA; Markley JL
    Biochemistry; 2003 Jun; 42(21):6380-91. PubMed ID: 12767219
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Probing intermolecular main chain hydrogen bonding in serine proteinase-protein inhibitor complexes: chemical synthesis of backbone-engineered turkey ovomucoid third domain.
    Lu W; Qasim MA; Laskowski M; Kent SB
    Biochemistry; 1997 Jan; 36(4):673-9. PubMed ID: 9020764
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Computational analysis of the binding of P1 variants of domain 3 of turkey ovomucoid inhibitor to Streptomyces griseus protease B.
    Fujinaga M; Huang K; Bateman KS; James MN
    J Mol Biol; 1998 Dec; 284(5):1683-94. PubMed ID: 9878379
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Protein inhibitors of serine proteinases: role of backbone structure and dynamics in controlling the hydrolysis constant.
    Song J; Markley JL
    Biochemistry; 2003 May; 42(18):5186-94. PubMed ID: 12731859
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Deleterious effects of beta-branched residues in the S1 specificity pocket of Streptomyces griseus proteinase B (SGPB): crystal structures of the turkey ovomucoid third domain variants Ile18I, Val18I, Thr18I, and Ser18I in complex with SGPB.
    Bateman KS; Anderson S; Lu W; Qasim MA; Laskowski M; James MN
    Protein Sci; 2000 Jan; 9(1):83-94. PubMed ID: 10739250
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Additivity-based design of the strongest possible turkey ovomucoid third domain inhibitors for porcine pancreatic elastase (PPE) and Streptomyces griseus protease B (SGPB).
    Qasim MA; Wang L; Qasim S; Lu S; Lu W; Wynn R; Yi ZP; Laskowski M
    FEBS Lett; 2013 Sep; 587(18):3021-6. PubMed ID: 23892073
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of eglin-c binding to thermitase: three-dimensional structure comparison of native thermitase and thermitase eglin-c complexes.
    Gros P; Teplyakov AV; Hol WG
    Proteins; 1992 Jan; 12(1):63-74. PubMed ID: 1553381
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Predicting proteinase specificities from free energy calculations.
    Mekonnen SM; Olufsen M; SmalÄs AO; Brandsdal BO
    J Mol Graph Model; 2006 Oct; 25(2):176-85. PubMed ID: 16386933
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Solution structure of reactive-site hydrolyzed turkey ovomucoid third domain by nuclear magnetic resonance and distance geometry methods.
    Walkenhorst WF; Krezel AM; Rhyu GI; Markley JL
    J Mol Biol; 1994 Sep; 242(3):215-30. PubMed ID: 8089843
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Structural and functional study of an Anemonia elastase inhibitor, a "nonclassical" Kazal-type inhibitor from Anemonia sulcata.
    Hemmi H; Kumazaki T; Yoshizawa-Kumagaye K; Nishiuchi Y; Yoshida T; Ohkubo T; Kobayashi Y
    Biochemistry; 2005 Jul; 44(28):9626-36. PubMed ID: 16008348
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Interscaffolding additivity: binding of P1 variants of bovine pancreatic trypsin inhibitor to four serine proteases.
    Krowarsch D; Dadlez M; Buczek O; Krokoszynska I; Smalas AO; Otlewski J
    J Mol Biol; 1999 May; 289(1):175-86. PubMed ID: 10339415
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Phage display selection of P1 mutants of BPTI directed against five different serine proteinases.
    Kiczak L; Koscielska K; Otlewski J; Czerwinski M; Dadlez M
    Biol Chem; 1999 Jan; 380(1):101-5. PubMed ID: 10064144
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.